Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EONS 2020 | Immunotherapy toxicities and checkpoint inhibitor therapy

Andreas Charalambous • 16 Sep 2020
EONS 2020 ESMO 2020
General

Andreas Charalambous, PhD, Cyprus University of Technology, Limassol, Cyprus, discusses immunotherapy-related toxicities and their link to immune checkpoint inhibitor therapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Andreas Charalambous

9:00
Fulfilling unmet supportive care needs of patients with lung cancer
Andreas Charalambous • 22 Mar 2021
5:05
Development of the cancer nursing workforce
Andreas Charalambous • 23 Nov 2020
3:09
Impact of COVID-19 on oncology nursing
Andreas Charalambous • 23 Nov 2020
3:14
The Prolepsis project
Andreas Charalambous • 16 Sep 2020

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals